Negative impact of fresh-frozen plasma transfusion on prognosis after hepatic resection for liver metastases from colorectal cancer

Anticancer Research

Volumn 33, Issue 6, 2013, Pages 2723-2728

  Shiba, Hiroaki ^a   Ishida, Yuichi ^a   Haruki, Koichiro ^a   Furukawa, Kenei ^a   Fujiwara, Yuki ^a   Iwase, Ryota ^a   Ohkuma, Masahisa ^a   Ogawa, Masaichi ^a   Misawa, Takeyuki ^a   Yanaga, Katsuhiko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood transfusion; Colorectal cancer; Hepatic resection; Liver metastasis; Prognosis

Indexed keywords

FRESH FROZEN PLASMA;

ADULT; AGED; ARTICLE; ASCITES; BILE LEAKAGE; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; COLORECTAL CANCER; DISTANT METASTASIS; ELECTIVE SURGERY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; INTESTINE OBSTRUCTION; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PLASMA TRANSFUSION; PLEURA EFFUSION; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL INFECTION; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; PLASMA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; SURVIVAL RATE; VERY ELDERLY;

BLOOD TRANSFUSION; COLORECTAL CANCER; HEPATIC RESECTION; LIVER METASTASIS; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COMPONENT TRANSFUSION; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PLASMA; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

MLCS; MLOWN;

EID: 84881348450     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Weitz J, Koch M, Debus J, Hohler T, Galle PR and Buchler MW: Colorectal cancer. Lancet 365: 153-165, 2005.
2. O'Reilly DA and Poston GJ: Colorectal liver metastases: Current and future perspectives. Future Oncol 2: 525-531, 2006.
3. Rodgers MS and McCall JL: Surgery for colorectal liver metastases with hepatic lymph node involvement: A systematic review. Br J Surg 87: 1142-1155, 2000.
4. Martin LW and Warren RS: Current management of colorectal liver metastases. Surg Oncol Clin N Am 9: 853-876, 2000.
5. Penna C and Nordlinger B: Colorectal metastasis (liver and lung). Surg Clin North Am 82: 1075-1090, 2002.
6. Kato T, Yasui K, Hirai T, Kanemitsu Y, Mori T, Sugihara K, Mochizuki H and Yamamoto J: Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: Analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 46: S22-31, 2003.
7. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P and Jaeck D: Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 77: 1254-1262, 1996.
8. Seifert JK, Bottger TC, Weigel TF, Gonner U and Junginger T: Prognostic factors following liver resection for hepatic metastases from colorectal cancer. Hepatogastroenterology 47: 239-246, 2000.
9. Fong Y, Fortner J, Sun RL, Brennan MF and Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 230: 309-321, 1999.
10. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, Yamamoto J and Imamura H: Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: Long-term results. Ann Surg 231: 487-499, 2000.
11. Jonas S, Thelen A, Benckert C, Spinelli A, Sammain S, Neumann U, Rudolph B and Neuhaus P: Extended resections of liver metastases from colorectal cancer. World J Surg 31: 511-521, 2007.
12. Brunson ME and Alexander JW: Mechanisms of transfusioninduced immunosuppression. Transfusion 30: 651-658, 1990.
13. Blajchman MA and Bordin JO: Mechanisms of transfusionassociated immunosuppression. Curr Opin Hematol 1: 457-461, 1994.
14. Blajchman MA: Immunomodulation and blood transfusion. Am J Ther 9: 389-395, 2002.
15. Magee CC and Sayegh MH: Peptide-mediated immunosuppression. Curr Opin Immunol 9: 669-675, 1997.
16. Krensky AM and Clayberger C: Structure of HLA molecules and immunosuppressive effects of HLA-derived peptides. Int Rev Immunol 13: 173-185, 1996.
17. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Mizuno S and Makuuchi M: Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 115: 303-309, 1994.
18. Yanaga K, Kanematsu T, Takenaka K, Matsumata T, Yoshida Y and Sugimachi K: Hepatic resection for hepatocellular carcinoma in elderly patients. Am J Surg 155: 238-241, 1988.
19. Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N and Morioka Y: Hepatic resection for hepatocellular carcinoma: Clinical features and long-term prognosis. Ann Surg 205: 22-40, 1987.
20. Asahara T, Katayama K, Itamoto T, Yano M, Hino H, Okamoto Y, Nakahara H, Dohi K, Moriwaki K and Yuge O: Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 23: 676-680, 1999.
21. Tralhao JG, Kayal S, Dagher I, Sanhueza M, Vons C and Franco D: Resection of hepatocellular carcinoma: The effect of surgical margin and blood transfusion on long-term survival. Analysis of 209 consecutive patients. Hepatogastroenterology 54: 1200-1206, 2007.
22. Sugita S, Sasaki A, Iwaki K, Uchida H, Kai S, Shibata K, Ohta M and Kitano S: Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: A retrospective study. Eur J Surg Oncol 34: 339-345, 2008.
23. Foster RS, Costanza MC, Foster JC, Wanner MC and Foster CB: Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer 55: 1195-1201, 1985.
24. Younes RN, Rogatko A and Brennan MF: The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg 214: 107-113, 1991.
25. Tartter PI: The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 216: 633-638, 1992.
26. Parrott NR, Lennard TW, Taylor RM, Proud G, Shenton BK and Johnston ID: Effect of perioperative blood transfusion on recurrence of colorectal cancer. Br J Surg 73: 970-973, 1986.
27. Blumberg N, Agarwal MM and Chuang C: Relation between recurrence of cancer of the colon and blood transfusion. Br Med J 290: 1037-1039, 1985.
28. Stephenson KR, Steinberg SM, Hughes KS, Vetto JT, Sugarbaker PH and Chang AE: Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg 208: 679-687, 1988.
29. Little AG, Wu HS, Ferguson MK, Ho CH, Bowers VD, Segalin A and Staszek VM: Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small cell lung cancer. Am J Surg 160: 630-632, 1990.
30. Tartter PI, Burrows L and Kirschner P: Perioperative blood transfusion adversely affects prognosis after resection of stage I (subset N0) non-oat cell lung cancer. J Thorac Cardiovasc Surg 88: 659-662, 1984.
31. Hyman NH, Foster RS, DeMeules JE and Costanza MC: Blood transfusions and survival after lung cancer resection. Am J Surg 149: 502-507, 1985.
32. Moores DW, Piantadosi S and McKneally MF: Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer. Ann Thorac Surg 47: 346-351, 1989.
33. Crowe JP, Gordon NH, Fry DE, Shuck JM and Hubay CA: Breast cancer survival and perioperative blood transfusion. Surgery 106: 836-841, 1989.
34. Nowak MM and Ponsky JL: Blood transfusion and disease-free survival in carcinoma of the breast. J Surg Oncol 27: 124-130, 1984.
35. Kaneda M, Horimi T, Ninomiya M, Nagae M, Mukai K, Takeda I, Shimoyama H, Chohno S, Okabayashi T and Kagawa S: Adverse affect of blood transfusions on survival of patients with gastric cancer. Transfusion 27: 375-377, 1987.
36. Fong Y, Karpeh M, Mayer K and Brennan MF: Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 167: 256-260, 1994.
37. Shiba H, Ishida Y, Wakiyama S, Iida T, Matsumoto M, Sakamoto T, Ito R, Gocho T, Furukawa K, Fujiwara Y, Hirohara S, Misawa T and Yanaga K: Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg 13: 1636-1642, 2009.
38. Shiba H, Ishii Y, Ishida Y, Wakiyama S, Sakamoto T, Ito R, Gocho T, Uwagawa T, Hirohara S, Kita Y, Misawa T and Yanaga K: Assessment of blood product use as predictors of pulmonary complications and surgical site infection after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 16: 69-74, 2009.
39. Haruki K, Shiba H, Fujiwara Y, Furukawa K, Wakiyama S, Ogawa M, Ishida Y, Misawa T and Yanaga K: Negative impact of surgical site infection on long-term outcomes after hepatic resection for colorectal liver metastases. Anticancer Res 33: 1697-1703, 2013.
40. Miyagawa S, Makuuchi M, Kawasaki S and Kakazu T: Criteria for safe hepatic resection. Am J Surg 169: 589-594, 1995.
41. Japanese Bureau of Medical Safety, Ministry of Health and Welfare. Guidelines for administering blood preparations. Medical and Pharmaceutial Notification No. 715, 10 June, 1999.
42. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ and Cameron JL: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235: 759-766, 2002.
43. Taieb J, Artru P, Paye F, Louvet C, Perez N, Andre T, Gayet B, Hebbar M, Goebel FM, Tournigand C, Parc R and de Gramont A: Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: Results of a phase II study. J Clin Oncol 23: 502-509, 2005.
44. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U,Van Cutsem E, Scheithauer W and Gruenberger T: Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial. Lancet 371: 1007-1016, 2008.
45. Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM and McWilliams RR: Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27: 3677-3683, 2009.
46. Vamvakas EC and Carven JH: Exposure to allogeneic plasma and risk of postoperative pneumonia and/or infection in coronary artery bypass graft surgery. Transfusion 42: 107-113, 2002.
47. Ashkenazi A and Dixit VM: Death receptors: Signaling and modulation. Science 281: 1305-1308, 1998.
48. Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D and Ashkenazi A: Genomic amplification of a decoy receptor for FAS ligand in lung and colon cancer. Nature 396: 699-703, 1998.
49. Ghio M, Contini P, Mazzei C, Brenci S, Barberis G, Filaci G, Indiveri F and Puppo F: Soluble HLA class I, HLA class II, and FAS ligand in blood components: A possible key to explain the immnomodulatory effects of allogeneic blood transfusions. Blood 93: 1770-1777, 1999.
50. Puppo F, Contini P, Ghio M, Brenci S, Scudeletti M, Filaci G, Ferrone S and Indiveri F: Soluble human MHC class I molecules induce soluble FAS ligand secretion and trigger apoptosis in activated CD8(+) FAS (CD95)(+) T lymphocytes. Int Immunol 12: 195-203, 2000.
51. Puppo F, Ghio M, Contini P, Mazzei C and Indiveri F: FAS, FAS ligand, and transfusion immunomodulation. Transfusion 41: 416-418, 2001.